Stock Analysis
Elevance Health Inc. (ELV) Stock Analysis
Elevance Health Inc. (ELV) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.
Elevance Health Inc. (ELV) currently has an AIQ Score of 59/100, indicating a neutral setup. Value is the strongest factor at 67/100. Quality is the weakest current factor at 48/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
ELV at a Glance
Crawlable current metrics from the latest market-close stock snapshot.
| Metric | Current |
|---|---|
| Price | $420.07 |
| AIQ Score | 59/100 |
| Overall View | Neutral |
| Technical Analysis Consensus | Neutral |
| Market Cap | $95.41B |
| P/E Ratio (TTM) | 18.74 |
| Forward P/E | — |
| EPS (quarter ended 2026-09-30) | $6.30 |
| Revenue (quarter ended 2026-09-30) | $51.43B |
| Dividend Yield (TTM) | 1.56% |
| Beta | 0.7 |
| Volume | 1.29M |
| 52-week range | $274.84-$450.69 |
| RSI 14 | 55.58 |
| 50-Day SMA | $410.09 |
| 200-Day SMA | $372.12 |
| Analyst Price Target | $458.81 |
| Next Earnings | Jan 27, 2027 |
ELVElevance Health Inc.
Healthcare / Medical - Healthcare Plans
Low Priority
Above Peers
Latest quote
- Momentum62
- Value67
- Quality48
- Risk resilience60
- Sentiment—
ELV Stock Analysis Summary
Elevance Health Inc. (ELV) currently has an AIQ Score of 59/100, indicating a neutral setup. Value is the strongest factor at 67/100. Quality is the weakest current factor at 48/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.
In a neutral regime, ELV has AIQ Score of 59/100 with Value base of 67/100 and fading Quality at 48/100. Wait for component alignment before adding exposure.
Healthcare · -0.46% stock move · ELV classified in Medical - Healthcare Plans.
Current Evidence
AlgovestIQ Evidence Summary
Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.
Is ELV Bullish or Bearish Right Now?
ELV currently has a neutral overall setup. Value is the strongest factor at 67/100, while Quality is weakest at 48/100. The current evidence suggests a mixed rather than strongly bullish or bearish setup.
- - Momentum is constructive at 62/100.
- - Risk Resilience is supportive at 60/100.
- - Price is +2.91% above its 50-day SMA.
- - Analyst target implies +9.22% upside from the latest quote.
- - Technical consensus has more buy votes than sell votes (21 vs 16).
- - No strong bearish evidence is available in the current snapshot.
Current Consensus
ELV's Technical Analysis Consensus is currently Neutral, with 21 buy, 8 neutral, and 16 sell votes. ELV's 14-day RSI is 55.58, which places the stock in a constructive momentum range. ELV's beta is 0.7, indicating lower market sensitivity than the broad market.
What Changed in ELV?
The largest recent change in ELV is Momentum moving down by 28.0 points over the available 7-day comparison window. Value remains the strongest visible factor.
What Would Change the ELV Outlook?
The current neutral outlook could improve if AIQ moves above 70, momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 40, price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.
AIQ > 70, RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.
AIQ below 40, RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.
ELV Decision Framework
Public evidence layers, setup checks, and risk context for Elevance Health Inc..
Elevance Health Inc. (ELV) Stock Analysis
Elevance Health Inc. has an AIQ Score of 59/100 in a Neutral regime. Value is strongest at 67/100. Beta is 0.71, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.
| Evidence Layer | Public Evidence |
|---|---|
| Regime Context | ELV is in a Neutral AIQ regime with score 59/100. |
| Signal Conflict | The primary conflict is that value leads at 67/100 while quality lags at 48/100. |
| Factor Evidence | Momentum 62/100 · Value 67/100 · Quality 48/100 · Risk 60/100 |
| Persistence | Current snapshot evidence is shown; historical persistence remains in AIQ Pro. |
Current Setup Checklist
Value is the strongest factor at 67/100.
Momentum is 62/100 and RSI (14) is 55.6.
ELV is in a Neutral regime at 59/100.
Risk factor is 60/100 with beta 0.71 and annual volatility 35.22%.
Current conflict: value leads at 67/100 while quality lags at 48/100.
ELV Research Cluster
Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.
ELV Fundamentals
ELV valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.
ELV Technical Analysis
ELV technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.
ELV Stock Catalysts
Track ELV earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.
ELV Dividend Analysis
ELV dividend yield, annual dividend, payout ratio, payment history, and income reliability context.
ELV Financial Data
ELV revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.
ELV Risk Analysis
ELV volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.
ELV Stock News
ELV stock news, market tone, recent headlines, and catalyst context.
ELV vs Healthcare Services / Managed Care Peers
Current peer cohort: ELV · HCA · HCAT · HIMS · HSIC. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.
| Peer | AIQ | Value | Momentum | Risk | Sharpe | 1Y Volatility | Compare |
|---|---|---|---|---|---|---|---|
| ELV Current stock | 59/100 | 67/100 | 62/100 | 60/100 | 0.71 | 35.22% | Current |
| HCA HCA Healthcare | 58/100 | 67/100 | 72/100 | 44/100 | 0.1 | 31.29% | ELV vs HCA |
| HCAT Health Catalyst | 51/100 | 73/100 | 63/100 | 39/100 | -0.3 | 90.48% | ELV vs HCAT |
| HIMS Hims & Hers Health | 43/100 | 58/100 | 57/100 | 19/100 | -0.13 | 89.04% | ELV vs HIMS |
| HSIC Henry Schein | 55/100 | 65/100 | 57/100 | 64/100 | 1.26 | 25.53% | ELV vs HSIC |
Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Oct 29, 2026.
About the AIQ Score
Methodology for the current stock evidence.
The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.
View AIQ methodologyFactor Diagnostics
A compact bridge from the AIQ score to the evidence tabs.
Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.
AIQ Component Profile
Compare the five component scores on one consistent 0–100 scale.
Review earnings timing, revisions, news pressure, and prior event reactions in one place.
Open catalysts4 recent quarterly periods are available for review.
Checked Oct 31, 2026
Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.
Fundamentals Verdict
Current snapshot fields are separate from reported-quarter statement tables.
Latest period Sep 30, 2026.
Market Confirmation
Technicals are summarized first, with the indicator library behind it.
Risk Alignment
Higher resilience is stronger; exposure metrics stay separate.
Continue Researching ELV
Open the detailed evidence pages and workflows behind the stock overview read.
Premium Feature
Full AIQ Analysis
AIQ Intelligence
AIQ Pro for ELV
Scenario Analysis
AIQ Scenario Builder
Portfolio Implication
Related Links
ELV Stock FAQ
What is ELV stock price today?
Elevance Health Inc.'s current stock price is $420.07. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.
Is ELV bullish or bearish right now?
ELV's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.
What is ELV's market cap?
ELV's market cap is $95.41B based on the latest completed market-close snapshot from Oct 30, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.
What is ELV's current P/E ratio?
ELV's current P/E ratio is 18.74 based on the latest completed market-close snapshot from Oct 30, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.
What is ELV's RSI?
ELV's 14-day RSI is 55.58 based on the latest completed market-close snapshot from Oct 30, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.
Is ELV above its 50-day and 200-day moving averages?
ELV is 2.91% from its 50-day SMA and 13.41% from its 200-day SMA based on the latest completed market-close snapshot from Oct 30, 2026. Moving-average position should be read with momentum and broader AIQ evidence.
When is ELV's next earnings date?
ELV's next earnings date is currently listed as Jan 27, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.
Does ELV pay a dividend?
ELV's dividend yield is 1.56% based on the latest completed market-close snapshot from Oct 30, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.